ProQR Therapeutics N.V. (PRQR) at a glance

ProQR Therapeutics N.V. (PRQR) is a micro-cap Healthcare company. It trades at $2.33, with a 0% profit margin and revenue decline of 57.1%. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Growth (11/100). It is a relatively defensive holding with below-market volatility.

Price

$2.34

Market cap

$151.7M

P/E ratio

n/a

Dividend yield

None

Beta

0.06

52-week range

$1.33 to $3.10